TreeWAS – Variant ID: rs11753401

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.905	0.095	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.884	0.116	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.826	0.174	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.802	0.198	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.789	0.211	0.000
C81 Hodgkin's disease	0.779	0.221	0.000
C83.3 Large cell (diffuse)	0.764	0.236	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.757	0.243	0.000
R31 Unspecified haematuria	0.754	0.246	0.000
C82.3 Follicular lymphoma grade IIIa	0.746	0.254	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.727	0.273	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.716	0.284	0.000
C82.0 Small cleaved cell, follicular	0.706	0.294	0.000
C81.9 Hodgkin's disease, unspecified	0.698	0.302	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.664	0.336	0.000
C81.0 Lymphocytic predominance	0.657	0.343	0.000
C83.1 Small cleaved cell (diffuse)	0.648	0.351	0.000
C82.6 Cutaneous follicle centre lymphoma	0.634	0.366	0.000
C82.5 Diffuse follicle centre lymphoma	0.634	0.366	0.000
C82.4 Follicular lymphoma grade IIIb	0.634	0.366	0.000
C82.2 Large cell, follicular	0.634	0.366	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.630	0.370	0.000
C85.1 B-cell lymphoma, unspecified	0.623	0.377	0.000
C81.2 Mixed cellularity	0.620	0.380	0.000
C83.7 Burkitt's tumour	0.618	0.382	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.596	0.404	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.592	0.407	0.000
C94 Other leukaemias of specified cell type	0.592	0.407	0.000
C93 Monocytic leukaemia	0.592	0.407	0.000
C86 Other specified types of T/NK-cell lymphoma	0.592	0.407	0.000
C83.6 Undifferentiated (diffuse)	0.575	0.425	0.000
C83.5 Lymphoblastic (diffuse)	0.575	0.425	0.000
C83.4 Immunoblastic (diffuse)	0.575	0.425	0.000
C83.2 Mixed small and large cell (diffuse)	0.575	0.425	0.000
C95 Leukaemia of unspecified cell type	0.569	0.431	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.565	0.434	0.000
C85.0 Lymphosarcoma	0.565	0.434	0.000
C81.7 Other Hodgkin's disease	0.558	0.441	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.558	0.441	0.000
C81.3 Lymphocytic depletion	0.558	0.441	0.000
C81.1 Nodular sclerosis	0.547	0.453	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.545	0.455	0.000
K90 Intestinal malabsorption	0.000	0.464	0.536
C88 Malignant immunoproliferative diseases	0.534	0.466	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.533	0.467	0.000
M45 Ankylosing spondylitis	0.529	0.471	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.476	0.524	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.472	0.528	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.468	0.532	0.000
T42.4 Benzodiazepines	0.467	0.533	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.456	0.544	0.000
C83.0 Small cell (diffuse)	0.454	0.545	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.445	0.555	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.558	0.442
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.433	0.567	0.000
T43.2 Other and unspecified antidepressants	0.431	0.569	0.000
C84.0 Mycosis fungoides	0.427	0.573	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.425	0.575	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.425	0.575	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.425	0.575	0.000
C86.4 Blastic NK-cell lymphoma	0.425	0.575	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.425	0.575	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.425	0.575	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.425	0.575	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.425	0.575	0.000
C93.9 Monocytic leukaemia, unspecified	0.425	0.575	0.000
C93.7 Other monocytic leukaemia	0.425	0.575	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.425	0.575	0.000
C93.2 Subacute monocytic leukaemia	0.425	0.575	0.000
C93.1 Chronic monocytic leukaemia	0.425	0.575	0.000
C93.0 Acute monocytic leukaemia	0.425	0.575	0.000
C94.7 Other specified leukaemias	0.425	0.575	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.425	0.575	0.000
C94.5 Acute myelofibrosis	0.425	0.575	0.000
C94.4 Acute panmyelosis	0.425	0.575	0.000
C94.3 Mast cell leukaemia	0.425	0.575	0.000
C94.2 Acute megakaryoblastic leukaemia	0.425	0.575	0.000
C94.1 Chronic erythraemia	0.425	0.575	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.425	0.575	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.425	0.575	0.000
C96.8 Histiocytic sarcoma	0.425	0.575	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.425	0.575	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.425	0.575	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.425	0.575	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.425	0.575	0.000
C96.3 True histiocytic lymphoma	0.425	0.575	0.000
C96.2 Malignant mast cell tumour	0.425	0.575	0.000
C96.1 Malignant histiocytosis	0.425	0.575	0.000
C96.0 Letterer-Siwe disease	0.425	0.575	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.417	0.583	0.000
C92 Myeloid leukaemia	0.414	0.586	0.000
C95.7 Other leukaemia of unspecified cell type	0.408	0.592	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.408	0.592	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.408	0.592	0.000
C95.0 Acute leukaemia of unspecified cell type	0.408	0.592	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.406	0.594	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.400	0.600	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.391	0.609	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.391	0.609	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.391	0.609	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.391	0.609	0.000
C84.3 Lymphoepithelioid lymphoma	0.391	0.609	0.000
C84.2 T-zone lymphoma	0.391	0.609	0.000
C84.1 Sezary's diease	0.391	0.609	0.000
K90.8 Other intestinal malabsorption	0.000	0.615	0.384
K90.3 Pancreatic steatorrhoea	0.000	0.615	0.384
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.615	0.384
K90.1 Tropical sprue	0.000	0.615	0.384
C95.9 Leukaemia, unspecified	0.384	0.616	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.383	0.617	0.000
C88.7 Other malignant immunoproliferative diseases	0.383	0.617	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.383	0.617	0.000
C88.3 Immunoproliferative small intestinal disease	0.383	0.617	0.000
C88.2 Gamma heavy chain disease	0.383	0.617	0.000
C88.1 Alpha heavy chain disease	0.383	0.617	0.000
T40.2 Other opioids	0.383	0.617	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.380	0.620	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.380	0.620	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.380	0.620	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.380	0.620	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.380	0.620	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.380	0.620	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.380	0.620	0.000
T42.0 Hydantoin derivatives	0.374	0.626	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.367	0.633	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.365	0.635	0.000
C84.5 Other and unspecified T-cell lymphomas	0.361	0.639	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.358	0.642	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.356	0.644	0.000
C91 Lymphoid leukaemia	0.353	0.645	0.001
T36 Poisoning by systemic antibiotics	0.348	0.652	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.348	0.652	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.657	0.343
T43.6 Psychostimulants with abuse potential	0.342	0.658	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.341	0.659	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.341	0.659	0.000
T42.3 Barbiturates	0.341	0.659	0.000
T42.2 Succinimides and oxazolidinediones	0.341	0.659	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.339	0.661	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.339	0.661	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.339	0.661	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.339	0.661	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.338	0.661	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.337	0.663	0.000
T42.1 Iminostilbenes	0.331	0.669	0.000
T43.9 Psychotropic drug, unspecified	0.327	0.673	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.327	0.673	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.327	0.673	0.000
T40.4 Other synthetic narcotics	0.327	0.673	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.324	0.675	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.324	0.676	0.000
C84.4 Peripheral T-cell lymphoma	0.323	0.677	0.000
T50.8 Diagnostic agents	0.311	0.689	0.000
T50.7 Analeptics and opioid receptor antagonists	0.311	0.689	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.311	0.689	0.000
T50.5 Appetite depressants	0.311	0.689	0.000
T50.4 Drugs affecting uric acid metabolism	0.311	0.689	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.311	0.689	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.311	0.689	0.000
T50.1 Loop [high-ceiling] diuretics	0.311	0.689	0.000
T50.0 Mineralocorticoids and their antagonists	0.311	0.689	0.000
T40.6 Other and unspecified narcotics	0.309	0.691	0.000
T38.1 Thyroid hormones and substitutes	0.306	0.694	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.305	0.695	0.000
T40.8 Lysergide [LSD]	0.305	0.695	0.000
T40.7 Cannabis (derivatives)	0.305	0.695	0.000
T40.5 Cocaine	0.305	0.695	0.000
T40.3 Methadone	0.305	0.695	0.000
T40.1 Heroin	0.305	0.695	0.000
T40.0 Opium	0.305	0.695	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.304	0.696	0.000
C92.9 Myeloid leukaemia, unspecified	0.297	0.703	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.297	0.703	0.000
C92.7 Other myeloid leukaemia	0.297	0.703	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.297	0.703	0.000
C92.5 Acute myelomonocytic leukaemia	0.297	0.703	0.000
C92.4 Acute promyelocytic leukaemia	0.297	0.703	0.000
C92.3 Myeloid sarcoma	0.297	0.703	0.000
C92.2 Subacute myeloid leukaemia	0.297	0.703	0.000
T45.0 Antiallergic and antiemetic drugs	0.291	0.709	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.291	0.709	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.290	0.710	0.000
C91.9 Lymphoid leukaemia, unspecified	0.277	0.722	0.001
T45.5 Anticoagulants	0.273	0.727	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.272	0.728	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.269	0.731	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.263	0.737	0.000
T45.8 Other primarily systemic and haematological agents	0.263	0.737	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.263	0.737	0.000
T45.6 Fibrinolysis-affecting drugs	0.263	0.737	0.000
T45.4 Iron and its compounds	0.263	0.737	0.000
T45.3 Enzymes, not elsewhere classified	0.263	0.737	0.000
T45.2 Vitamins, not elsewhere classified	0.263	0.737	0.000
T38.9 Other and unspecified hormone antagonists	0.262	0.738	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.262	0.738	0.000
T38.7 Androgens and anabolic congeners	0.262	0.738	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.262	0.738	0.000
T38.5 Other oestrogens and progestogens	0.262	0.738	0.000
T38.4 Oral contraceptives	0.262	0.738	0.000
T38.2 Antithyroid drugs	0.262	0.738	0.000
T38.0 Glucocorticoids and synthetic analogues	0.262	0.738	0.000
T36.0 Penicillins	0.259	0.740	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.255	0.742	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.255	0.745	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.255	0.745	0.000
T47.7 Emetics	0.255	0.745	0.000
T47.6 Antidiarrhoeal drugs	0.255	0.745	0.000
T47.5 Digestants	0.255	0.745	0.000
T47.4 Other laxatives	0.255	0.745	0.000
T47.3 Saline and osmotic laxatives	0.255	0.745	0.000
T47.2 Stimulant laxatives	0.255	0.745	0.000
T47.0 Histamine H(2)-receptor antagonists	0.255	0.745	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.254	0.745	0.001
C91.7 Other lymphoid leukaemia	0.254	0.745	0.001
C91.6 Prolymphocytic leukaemia of T-cell type	0.254	0.745	0.001
C91.5 Adult T-cell leukaemia	0.254	0.745	0.001
C91.4 Hairy-cell leukaemia	0.254	0.745	0.001
C91.3 Prolymphocytic leukaemia	0.254	0.745	0.001
C91.2 Subacute lymphocytic leukaemia	0.254	0.745	0.001
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.254	0.745	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.252	0.748	0.000
T36.9 Systemic antibiotic, unspecified	0.250	0.750	0.000
T36.8 Other systemic antibiotics	0.250	0.750	0.000
T36.7 Antifungal antibiotics, systemically used	0.250	0.750	0.000
T36.6 Rifamycins	0.250	0.750	0.000
T36.5 Aminoglycosides	0.250	0.750	0.000
T36.4 Tetracyclines	0.250	0.750	0.000
T36.3 Macrolides	0.250	0.750	0.000
T36.2 Chloramphenicol group	0.250	0.750	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.250	0.750	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.250	0.750	0.000
T39.4 Antirheumatics, not elsewhere classified	0.250	0.750	0.000
T39.2 Pyrazolone derivatives	0.250	0.750	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.243	0.757	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.243	0.757	0.000
T37.5 Antiviral drugs	0.243	0.757	0.000
T37.4 Anthelminthics	0.243	0.757	0.000
T37.3 Other antiprotozoal drugs	0.243	0.757	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.243	0.757	0.000
T37.1 Antimycobacterial drugs	0.243	0.757	0.000
T37.0 Sulphonamides	0.243	0.757	0.000
T41.5 Therapeutic gases	0.243	0.757	0.000
T41.4 Anaesthetic, unspecified	0.243	0.757	0.000
T41.3 Local anaesthetics	0.243	0.757	0.000
T41.2 Other and unspecified general anaesthetics	0.243	0.757	0.000
T41.1 Intravenous anaesthetics	0.243	0.757	0.000
T41.0 Inhaled anaesthetics	0.243	0.757	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.243	0.757	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.243	0.757	0.000
T48.5 Anti-common-cold drugs	0.243	0.757	0.000
T48.4 Expectorants	0.243	0.757	0.000
T48.3 Antitussives	0.243	0.757	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.243	0.757	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.243	0.757	0.000
T48.0 Oxytocic drugs	0.243	0.757	0.000
T49.9 Topical agent, unspecified	0.243	0.757	0.000
T49.8 Other topical agents	0.243	0.757	0.000
T49.7 Dental drugs, topically applied	0.243	0.757	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.243	0.757	0.000
T49.5 Ophthalmological drugs and preparations	0.243	0.757	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.243	0.757	0.000
T49.3 Emollients, demulcents and protectants	0.243	0.757	0.000
T49.2 Local astringents and local detergents	0.243	0.757	0.000
T49.1 Antipruritics	0.243	0.757	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.243	0.757	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.243	0.757	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.243	0.757	0.000
T46.7 Peripheral vasodilators	0.243	0.757	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.243	0.757	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.243	0.757	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.243	0.757	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.243	0.757	0.000
C92.1 Chronic myeloid leukaemia	0.241	0.759	0.000
T39.0 Salicylates	0.235	0.765	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.232	0.768	0.000
T46.1 Calcium-channel blockers	0.215	0.784	0.000
C92.0 Acute myeloid leukaemia	0.214	0.786	0.000
C91.0 Acute lymphoblastic leukaemia	0.208	0.791	0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.193	0.807	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.193	0.807	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.193	0.807	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.193	0.807	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.193	0.807	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.193	0.807	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.193	0.807	0.000
T44.0 Anticholinesterase agents	0.193	0.807	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.191	0.809	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.186	0.813	0.000
C90.3 Solitary plasmacytoma	0.183	0.815	0.002
C90.1 Plasma cell leukaemia	0.183	0.815	0.002
T39.1 4-Aminophenol derivatives	0.170	0.830	0.000
E03.9 Hypothyroidism, unspecified	0.144	0.856	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.135	0.864	0.000
C90.2 Plasmacytoma, extramedullary	0.120	0.877	0.003
K90-K93 Other diseases of the digestive system	0.000	0.885	0.115
M45-M49 Spondylopathies	0.098	0.902	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.000	0.917	0.083
M46 Other inflammatory spondylopathies	0.082	0.918	0.000
K92 Other diseases of digestive system	0.000	0.921	0.079
K92.2 Gastro-intestinal haemorrhage, unspecified	0.000	0.926	0.074
M46.9 Inflammatory spondylopathy, unspecified	0.073	0.927	0.000
E03 Other hypothyroidism	0.069	0.931	0.000
M49 Spondylopathies in diseases classified elsewhere	0.066	0.934	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.000	0.940	0.060
K93.1 Megacolon in Chagas' disease	0.000	0.940	0.060
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.000	0.940	0.060
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.060	0.940	0.000
M46.8 Other specified inflammatory spondylopathies	0.059	0.941	0.000
M46.5 Other infective spondylopathies	0.059	0.941	0.000
M46.3 Infection of intervertebral disk (pyogenic)	0.059	0.941	0.000
M46.2 Osteomyelitis of vertebra	0.059	0.941	0.000
M46.0 Spinal enthesopathy	0.059	0.941	0.000
M46.1 Sacro-iliitis, not elsewhere classified	0.059	0.941	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.059	0.941	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.058	0.942	0.000
K92.1 Melaena	0.000	0.942	0.058
M46.4 Discitis, unspecified	0.056	0.944	0.000
M48 Other spondylopathies	0.053	0.947	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.052	0.948	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.052	0.948	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.052	0.948	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.052	0.948	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.052	0.948	0.000
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.051	0.949	0.000
C91.1 Chronic lymphocytic leukaemia	0.048	0.949	0.003
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.050	0.950	0.000
E03.5 Myxoedema coma	0.049	0.950	0.000
E03.4 Atrophy of thyroid (acquired)	0.049	0.950	0.000
E03.3 Postinfectious hypothyroidism	0.049	0.950	0.000
E03.1 Congenital hypothyroidism without goitre	0.049	0.950	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.049	0.950	0.000
K92.9 Disease of digestive system, unspecified	0.000	0.950	0.049
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.049	0.951	0.000
M49.8 Spondylopathy in other diseases classified elsewhere	0.047	0.952	0.000
M49.4 Neuropathic spondylopathy	0.047	0.952	0.000
M49.3 Spondylopathy in other infectious and parasitic diseases classified elsewhere	0.047	0.952	0.000
M49.2 Enterobacterial spondylitis	0.047	0.952	0.000
M49.1 Brucella spondylitis	0.047	0.952	0.000
M49.0 Tuberculosis of spine	0.047	0.952	0.000
K92.8 Other specified diseases of digestive system	0.000	0.956	0.044
M49.5 Collapsed vertebra in diseases classified elsewhere	0.043	0.957	0.000
M46.09 Spinal enthesopathy (Site unspecified)	0.043	0.957	0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.043	0.957	0.000
M46.07 Spinal enthesopathy (Lumbosacral region)	0.043	0.957	0.000
M46.06 Spinal enthesopathy (Lumbar region)	0.043	0.957	0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.043	0.957	0.000
M46.04 Spinal enthesopathy (Thoracic region)	0.043	0.957	0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.043	0.957	0.000
M46.02 Spinal enthesopathy (Cervical region)	0.043	0.957	0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.043	0.957	0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.043	0.957	0.000
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.043	0.957	0.000
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)	0.043	0.957	0.000
M46.27 Osteomyelitis of vertebra (Lumbosacral region)	0.043	0.957	0.000
M46.26 Osteomyelitis of vertebra (Lumbar region)	0.043	0.957	0.000
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)	0.043	0.957	0.000
M46.24 Osteomyelitis of vertebra (Thoracic region)	0.043	0.957	0.000
M46.23 Osteomyelitis of vertebra (Cervicothoracic region)	0.043	0.957	0.000
M46.22 Osteomyelitis of vertebra (Cervical region)	0.043	0.957	0.000
M46.21 Osteomyelitis of vertebra (Occipito-atlanto-axial region)	0.043	0.957	0.000
M46.20 Osteomyelitis of vertebra (Multiple sites in spine)	0.043	0.957	0.000
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)	0.043	0.957	0.000
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)	0.043	0.957	0.000
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)	0.043	0.957	0.000
M46.36 Infection of intervertebral disc (pyogenic) (Lumbar region)	0.043	0.957	0.000
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)	0.043	0.957	0.000
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)	0.043	0.957	0.000
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)	0.043	0.957	0.000
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)	0.043	0.957	0.000
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)	0.043	0.957	0.000
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)	0.043	0.957	0.000
M46.59 Other infective spondylopathies (Site unspecified)	0.043	0.957	0.000
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.043	0.957	0.000
M46.57 Other infective spondylopathies (Lumbosacral region)	0.043	0.957	0.000
M46.56 Other infective spondylopathies (Lumbar region)	0.043	0.957	0.000
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.043	0.957	0.000
M46.54 Other infective spondylopathies (Thoracic region)	0.043	0.957	0.000
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.043	0.957	0.000
M46.52 Other infective spondylopathies (Cervical region)	0.043	0.957	0.000
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.043	0.957	0.000
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.043	0.957	0.000
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.043	0.957	0.000
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.043	0.957	0.000
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.043	0.957	0.000
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.043	0.957	0.000
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.043	0.957	0.000
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.043	0.957	0.000
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.043	0.957	0.000
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.043	0.957	0.000
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.043	0.957	0.000
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.043	0.957	0.000
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.042	0.957	0.000
M46.17 Sacroiliitis, not elsewhere classified-Lumbosacral	0.042	0.957	0.000
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.042	0.957	0.000
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.042	0.957	0.000
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.042	0.957	0.000
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.042	0.957	0.000
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.042	0.957	0.000
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.042	0.957	0.000
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.042	0.957	0.000
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.042	0.958	0.000
E03.8 Other specified hypothyroidism	0.041	0.959	0.000
M46.49 Discitis, unspecified (Site unspecified)	0.040	0.959	0.000
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.040	0.959	0.000
M46.47 Discitis, unspecified (Lumbosacral region)	0.040	0.959	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.040	0.959	0.000
M46.44 Discitis, unspecified (Thoracic region)	0.040	0.959	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.040	0.959	0.000
M46.42 Discitis, unspecified (Cervical region)	0.040	0.959	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.040	0.959	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.040	0.959	0.000
C90.0 Multiple myeloma	0.036	0.960	0.004
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.000	0.961	0.039
M48.9 Spondylopathy, unspecified	0.038	0.962	0.000
M48.8 Other specified spondylopathies	0.038	0.962	0.000
M48.4 Fatigue fracture of vertebra	0.038	0.962	0.000
M48.3 Traumatic spondylopathy	0.038	0.962	0.000
M48.2 Kissing spine	0.038	0.962	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.038	0.962	0.000
M46.46 Discitis, unspecified (Lumbar region)	0.037	0.963	0.000
J47 Bronchiectasis	0.037	0.963	0.000
J32.9 Chronic sinusitis, unspecified	0.037	0.963	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.036	0.964	0.000
K91.3 Postoperative intestinal obstruction	0.000	0.965	0.034
M49.09 Tuberculosis of spine (Site unspecified)	0.034	0.966	0.000
M49.08 Tuberculosis of spine (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.07 Tuberculosis of spine (Lumbosacral region)	0.034	0.966	0.000
M49.06 Tuberculosis of spine (Lumbar region)	0.034	0.966	0.000
M49.05 Tuberculosis of spine (Thoracolumbar region)	0.034	0.966	0.000
M49.04 Tuberculosis of spine (Thoracic region)	0.034	0.966	0.000
M49.03 Tuberculosis of spine (Cervicothoracic region)	0.034	0.966	0.000
M49.02 Tuberculosis of spine (Cervical region)	0.034	0.966	0.000
M49.01 Tuberculosis of spine (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.00 Tuberculosis of spine (Multiple sites in spine)	0.034	0.966	0.000
M49.19 Brucella spondylitis (Site unspecified)	0.034	0.966	0.000
M49.18 Brucella spondylitis (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.17 Brucella spondylitis (Lumbosacral region)	0.034	0.966	0.000
M49.16 Brucella spondylitis (Lumbar region)	0.034	0.966	0.000
M49.15 Brucella spondylitis (Thoracolumbar region)	0.034	0.966	0.000
M49.14 Brucella spondylitis (Thoracic region)	0.034	0.966	0.000
M49.13 Brucella spondylitis (Cervicothoracic region)	0.034	0.966	0.000
M49.12 Brucella spondylitis (Cervical region)	0.034	0.966	0.000
M49.11 Brucella spondylitis (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.10 Brucella spondylitis (Multiple sites in spine)	0.034	0.966	0.000
M49.29 Enterobacterial spondylitis (Site unspecified)	0.034	0.966	0.000
M49.28 Enterobacterial spondylitis (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.27 Enterobacterial spondylitis (Lumbosacral region)	0.034	0.966	0.000
M49.26 Enterobacterial spondylitis (Lumbar region)	0.034	0.966	0.000
M49.25 Enterobacterial spondylitis (Thoracolumbar region)	0.034	0.966	0.000
M49.24 Enterobacterial spondylitis (Thoracic region)	0.034	0.966	0.000
M49.23 Enterobacterial spondylitis (Cervicothoracic region)	0.034	0.966	0.000
M49.22 Enterobacterial spondylitis (Cervical region)	0.034	0.966	0.000
M49.21 Enterobacterial spondylitis (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.20 Enterobacterial spondylitis (Multiple sites in spine)	0.034	0.966	0.000
M49.39 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Site unspecified)	0.034	0.966	0.000
M49.38 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.37 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Lumbosacral region)	0.034	0.966	0.000
M49.36 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Lumbar region)	0.034	0.966	0.000
M49.35 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Thoracolumbar region)	0.034	0.966	0.000
M49.34 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Thoracic region)	0.034	0.966	0.000
M49.33 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Cervicothoracic region)	0.034	0.966	0.000
M49.32 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Cervical region)	0.034	0.966	0.000
M49.31 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.30 Spondylopathy in other infectious and parasitic diseases classified elsewhere (Multiple sites in spine)	0.034	0.966	0.000
M49.49 Neuropathic spondylopathy (Site unspecified)	0.034	0.966	0.000
M49.48 Neuropathic spondylopathy (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.47 Neuropathic spondylopathy (Lumbosacral region)	0.034	0.966	0.000
M49.46 Neuropathic spondylopathy (Lumbar region)	0.034	0.966	0.000
M49.45 Neuropathic spondylopathy (Thoracolumbar region)	0.034	0.966	0.000
M49.44 Neuropathic spondylopathy (Thoracic region)	0.034	0.966	0.000
M49.43 Neuropathic spondylopathy (Cervicothoracic region)	0.034	0.966	0.000
M49.42 Neuropathic spondylopathy (Cervical region)	0.034	0.966	0.000
M49.41 Neuropathic spondylopathy (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.40 Neuropathic spondylopathy (Multiple sites in spine)	0.034	0.966	0.000
M49.89 Spondylopathy in other diseases classified elsewhere (Site unspecified)	0.034	0.966	0.000
M49.88 Spondylopathy in other diseases classified elsewhere (Sacral and sacrococcygeal region)	0.034	0.966	0.000
M49.87 Spondylopathy in other diseases classified elsewhere (Lumbosacral region)	0.034	0.966	0.000
M49.86 Spondylopathy in other diseases classified elsewhere (Lumbar region)	0.034	0.966	0.000
M49.85 Spondylopathy in other diseases classified elsewhere (Thoracolumbar region)	0.034	0.966	0.000
M49.84 Spondylopathy in other diseases classified elsewhere (Thoracic region)	0.034	0.966	0.000
M49.83 Spondylopathy in other diseases classified elsewhere (Cervicothoracic region)	0.034	0.966	0.000
M49.82 Spondylopathy in other diseases classified elsewhere (Cervical region)	0.034	0.966	0.000
M49.81 Spondylopathy in other diseases classified elsewhere (Occipito-atlanto-axial region)	0.034	0.966	0.000
M49.80 Spondylopathy in other diseases classified elsewhere (Multiple sites in spine)	0.034	0.966	0.000
E00-E07 Disorders of thyroid gland	0.032	0.968	0.000
M49.59 Collapsed vertebra in diseases classified elsewhere (Site unspecified)	0.031	0.969	0.000
M49.58 Collapsed vertebra in diseases classified elsewhere (Sacral and sacrococcygeal region)	0.031	0.969	0.000
M49.57 Collapsed vertebra in diseases classified elsewhere (Lumbosacral region)	0.031	0.969	0.000
M49.56 Collapsed vertebra in diseases classified elsewhere (Lumbar region)	0.031	0.969	0.000
M49.55 Collapsed vertebra in diseases classified elsewhere (Thoracolumbar region)	0.031	0.969	0.000
M49.53 Collapsed vertebra in diseases classified elsewhere (Cervicothoracic region)	0.031	0.969	0.000
M49.52 Collapsed vertebra in diseases classified elsewhere (Cervical region)	0.031	0.969	0.000
M49.51 Collapsed vertebra in diseases classified elsewhere (Occipito-atlanto-axial region)	0.031	0.969	0.000
M49.50 Collapsed vertebra in diseases classified elsewhere (Multiple sites in spine)	0.031	0.969	0.000
J33.0 Polyp of nasal cavity	0.000	0.969	0.031
E07 Other disorders of thyroid	0.029	0.971	0.000
E06 Thyroiditis	0.028	0.971	0.000
K91.1 Postgastric surgery syndromes	0.000	0.972	0.028
K91.5 Postcholecystectomy syndrome	0.000	0.972	0.028

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations